KING STREET CAPITAL MANAGEMENT, L.P.KING STREET CAPITAL MANAGEMENT, L.P.

Institutional investor · Portfolio as of Q2 2026

Top Holdings6 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

SURGERY PARTNERS INC

6.1M$101.8M53.7%$23.05-39.09%
8 qtrssince 2024-Q3
Decreased
0
USHYUSHY
ETF

ISHARES BROAD USD HIGH YIELD

999,000$37M19.5%$36.60+0.98%
1 qtr
New
93
HYGHYG
ETF

ISHR IBX USD HIYLD CB ETF-UI

237,100$19M10.0%$79.22+0.86%
1 qtr
New
90

TALEN ENERGY CORP

47,000$18.1M9.5%$341.39-10.28%
2 qtrssince 2026-Q1
Unchanged
0

VISTRA CORP

59,000$9.4M4.9%$161.70-13.40%
2 qtrssince 2026-Q1
Unchanged
0

OPTIMUM COMMUNICATIONS INC

3.1M$4.5M2.4%$2.00-46.05%
4 qtrssince 2025-Q3
Decreased
0
$189.7M
AUM
6
Positions
Q2 2026
Filing
1.5/5
HI score
Quarterly 13F Value Change
+30%Q1'25$753.7M-16%Q2'25$632.2M+15%Q3'25$729.9M-1%Q4'25$724.3M-55%Q1'26$328M-42%Q2'26$189.7M
Activity profile
$ moved · Q2'26
New22%Increased0%Decreased10%Exited68%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.6 years
<1Q17%1-4Q33%1-2Y0%2Y+50%

KING STREET CAPITAL MANAGEMENT, L.P. manages $189.7M across 6 positions as of Q2 2026. Top holdings: SGRY (53.7%), USHY (19.5%), HYG (10.0%). Fund DNA: Momentum Trader. HoldingsIntel Score: 1.5/5.0.

Q2 2026 Summary

Active quarter - 2 new positions, 7 exits, 0 increased. Top move: USHY (NEW, conviction 93). Portfolio: $190M across 6 positions.

Top holdings by portfolio weight

Total AUM$190M
SGRY53.66%
USHY19.50%
HYG10.00%
TLN9.52%
VST4.93%
OPTU2.39%
AGNC0.00%
BA0.00%
BXSL0.00%
XLI0.00%

Portfolio allocation by GICS sector

Sectors4
Healthcare53.66%
Unknown29.50%
Utilities14.46%
Communication Services2.39%

Behavioral investing profile

Checking access…
Momentum Trader- primarily Healthcare, Unknown, Utilities
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Below Average(1.5 / 5.0)
Holdings P&L33
Conviction49
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

No active accumulation streaks detected for this filer.

Streaks require 2+ consecutive quarters of increased positions in the most recent period.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used